Filing Flows

Filing Flows › Sanofi (SNY) › Next earnings date

Sanofi (SNY) earnings: beat the estimate

Sanofi (SNY) reported on Oct 30, 2026 and beat the EPS estimate: $1.98 against $1.51 (+31.2%). Revenue was $14.4B for Q3 2026, +16% year over year. The stock moved +5.6% on the report. It beat the EPS estimate in 100% of the quarters on record.

Last result+31.2% vs estimate
Beat rate100%

The last report

Sanofi reported revenue of $14.4B for the third quarter 2026 (+16% Y/Y), net earnings $3.0B. How it makes money → · Every quarter →

Sanofi: EPS against the estimate, last 4 reportsSanofi: EPS against the estimate, last 4 reportsEstimateReported$0.85$0.91Jan 26$1.03$1.10Apr 26$1.14$1.20Jul 26$1.51$1.98Oct 26
Latest (Oct 26): Estimate $1.51, Reported $1.98.
SNY: the stock's move on each reportSNY: the stock's move on each reportOct 30, 2026+5.6%Jul 30, 2026-3.9%Apr 23, 2026-0.3%Jan 29, 2026+2.8%

Sanofi's latest quarter

Sanofi, Q3 2026: revenue $14.4B (+16% year over year), operating margin 30.1%, net earnings $3.0B, operating cash flow $3.9B. The chart follows the revenue to costs, profit and cash.

Questions

Did Sanofi beat earnings?

Sanofi (SNY) reported on Oct 30, 2026 and beat the EPS estimate: $1.98 against $1.51 (+31.2%).

When does SNY report earnings?

The next date is not set yet.

Does Sanofi usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.